MedMira
MedMira Receives Patent for its Unique Quantitative Diagnostic System
Halifax, Nova Scotia, June 6, 2022 – Today, MedMira Inc. (MedMira) (TSXV: MIR) announces the receipt of a U.S. patent (number 11,353,450)...
top of page
MedMira
- May 27, 2022
- 2 min
Update on the new In Vitro Diagnostic Medical Devices Regulation (IVDR) in the European Market
Halifax, Nova Scotia, 27 May, 2022 – Today, MedMira Inc. (MedMira) (TSXV: MIR) provides an update on its regulatory progress in Europe...
MedMira
- May 20, 2022
- 2 min
VYRA™ Product Line Update
Halifax, Nova Scotia, 20 May, 2022 – Today, MedMira Inc. (MedMira) (TSXV: MIR) provides an update on the Company’s regulatory work for...
MedMira
- May 18, 2022
- 1 min
Test yourself in a smart way
A fact sheet for the importance of testing for both TP/nTP. Multiplo Compete Syphilis (TP/nTP) Antibody Test - testing was never so easy...
MedMira
- May 12, 2022
- 2 min
MedMira receives CE mark for Multiplo® Complete Syphilis (TP/nTP) Antibody Test
Halifax, Nova Scotia, 12 May, 2022 – Today, MedMira Inc. (MedMira) (TSXV: MIR) announces the achievement of another milestone in its...
MedMira
- Apr 29, 2022
- 1 min
Practical Testing
Now available in a small box (5 Tests) ideal for travel or home use.
bottom of page